Double Helix appoints Hollie Durrance and Gavin Harper
pharmafile | January 18, 2011 | Appointment | Medical Communications |Â Â Double Helix, Gavin Harper, Hollie Durrance, appointment, medical communicationsÂ
Global market research consultancy Double Helix has appointed Hollie Durrance as research manager and Gavin Harper as trainee research executive within its strategic market research team, headquartered in London.
Hollie, a Psychology graduate, joins after four years at Insight Research Group and has managed studies using a variety of methodologies, both qualitative and quantitative in nature, in oncology, substance misuse, genetic disorders, travel health, rheumatoid arthritis, and mental health amongst others.
Gavin has a strong academic and research background, having graduated from the University of Leeds in 2010, with a first class honours degree in Linguistics and Phonetics.
Related Content

Men’s health – a new report from the Department of Health and Social Care
The UK Department of Health and Social Care has published a new report entitled Men’s …

PlasmidFactory founder Dr. Martin Schleef honoured with the NRW Innovation Award 2025
The founder and long-standing CEO of PlasmidFactory, Dr. Martin Schleef, was honoured in Düsseldorf with …

David Wheadon appointed to board of directors at Seaport Therapeutics
This week, Seaport Therapeutics have appointed David Wheadon MD to their board of directors.






